We are live on ! Find out more
OppenheimerFunds

OppenheimerFunds Portfolio holdings

AUM $80.4B Turnover 10.97%
1-Year Est. Return 15.1%
This Fund
S&P 500
This Quarter Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.06%
5 Year Est. Return
+90.96%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
Cap. Flow
-$1.63B
Cap. Flow %
-2.03%
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Avg Time Held
3.1 years
Top 10 Avg Time Held
1.2 years
Top 20 Avg Time Held
1.9 years

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$291M
2
PEP icon
PepsiCo
PEP
+$260M
3
BNY icon
Bank of New York Mellon
BNY
+$258M
4
AAPL icon
Apple
AAPL
+$221M
5
WES icon
Western Gas Partners
WES
+$215M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.13%
2 Technology 15.85%
3 Healthcare 13.96%
4 Energy 13.9%
5 Financials 12.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
FAST icon
76
Fastenal
FAST
$60.4B
$272M 0.34%
16,947,076
-1,471,432
-8% -$22.1M
2017 Q3
6 quarters
TIF
77
DELISTED
Tiffany & Co
TIF
$270M 0.34%
2,557,422
+11,966
+0.5% +$1.1M
2013 Q2
23 quarters
UPS icon
78
United Parcel Service
UPS
$92.9B
$269M 0.33%
2,405,908
+6,183
+0.3% +$656K
2013 Q2
23 quarters
EPAM icon
79
EPAM Systems
EPAM
$7.68B
$267M 0.33%
1,581,263
+165,855
+12% +$24.9M
2018 Q3
2 quarters
GOOG icon
80
Alphabet (Google) Class C
GOOG
$3.33T
$266M 0.33%
4,527,360
+134,220
+3% +$7.53M
2013 Q2
23 quarters
EQH icon
81
Equitable Holdings
EQH
$13.8B
$262M 0.33%
13,022,986
-223,996
-2% -$4.28M
2018 Q2
3 quarters
ORLY icon
82
O'Reilly Automotive
ORLY
$74.3B
$260M 0.32%
10,040,580
+93,225
+0.9% +$2.26M
2013 Q2
23 quarters
V icon
83
Visa
V
$751B
$258M 0.32%
1,649,383
+220,905
+15% +$31.8M
2013 Q2
23 quarters
BBY icon
84
Best Buy
BBY
$21B
$256M 0.32%
3,606,179
-527,750
-13% -$32.9M
2013 Q2
23 quarters
GILD icon
85
Gilead Sciences
GILD
$207B
$244M 0.3%
3,756,356
-2,498,109
-40% -$166M
2013 Q2
23 quarters
AVAL icon
86
Grupo Aval
AVAL
$4.29B
$243M 0.3%
31,216,276
-428,985
-1% -$3.09M
2014 Q3
18 quarters
BKNG icon
87
Booking.com
BKNG
$110B
$238M 0.3%
3,408,750
+244,875
+8% +$17.5M
2015 Q4
13 quarters
PFE icon
88
Pfizer
PFE
$157B
$237M 0.29%
5,883,786
-642,886
-10% -$25.7M
2013 Q2
23 quarters
CSCO icon
89
Cisco
CSCO
$373B
$236M 0.29%
4,372,033
-125,328
-3% -$6.09M
2013 Q2
23 quarters
WES icon
90
Western Midstream Partners
WES
$16.7B
$236M 0.29%
7,523,885
+7,486,165
+19,847% +$238M
2018 Q3
2 quarters
SAGE icon
91
DELISTED
Sage Therapeutics
SAGE
$230M 0.29%
1,443,145
+4,721
+0.3% +$684K
2016 Q1
12 quarters
RSG icon
92
Republic Services
RSG
$75.9B
$224M 0.28%
2,786,819
-54,029
-2% -$4.16M
2014 Q2
19 quarters
ITW icon
93
Illinois Tool Works
ITW
$80.2B
$221M 0.28%
1,541,319
-222,437
-13% -$30.8M
2015 Q4
13 quarters
BSX icon
94
Boston Scientific
BSX
$62.3B
$217M 0.27%
5,652,397
-462,003
-8% -$17.6M
2013 Q2
23 quarters
EXAS icon
95
DELISTED
Exact Sciences
EXAS
$217M 0.27%
2,500,206
-365,027
-13% -$31.1M
2015 Q2
15 quarters
BA icon
96
Boeing
BA
$127B
$214M 0.27%
560,411
+16,632
+3% +$6.4M
2013 Q2
23 quarters
ITUB icon
97
Itaú Unibanco
ITUB
$73.7B
$209M 0.26%
32,650,498
-447,344
-1% -$3.16M
2017 Q4
5 quarters
EFX icon
98
Equifax
EFX
$21B
$206M 0.26%
1,737,528
+15,617
+0.9% +$1.67M
2015 Q2
15 quarters
CHD icon
99
Church & Dwight
CHD
$26.4B
$201M 0.25%
2,825,630
-554,816
-16% -$36.5M
2016 Q1
12 quarters
STI icon
100
DELISTED
SunTrust Banks
STI
$200M 0.25%
3,380,622
+338,462
+11% +$20.7M
2013 Q2
23 quarters

Similar funds

OppenheimerFunds's Q1 2019 Portfolio in Review

As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
  • OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
  • OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
  • OppenheimerFunds fully exited Western Gas Partners in Q1 2019, selling an estimated $215M.
  • OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
  • OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
  • OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.